These effects, along with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assist the concept of targeting ACKR3 as a singular approach to modulate the opioid program, which could open up new therapeutic avenues for opioid-related Issues. Disclaimer: The above mentioned is https://nicolauss170txp9.atualblog.com/profile